# Effect of Propofol on Renal Injury in Patients Undergoing Valvular Heart Surgery

Study · id `cardio:ct-nct01384643` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01384643](<https://clinicaltrials.gov/study/NCT01384643>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01384643

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 112 participants.

## Technical summary

Registry record NCT01384643. Randomized; triple masking; primary purpose prevention. Start 2011-05 (registry gives no type); primary completion 2012-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 112 participants (enrolled count; ClinicalTrials.gov record NCT01384643, source copy `cardio:ctgov-nct01384643-2013-04-12`, retrieved 2026-10-26)
- Start date: 2011-05 (registry gives no type) (ClinicalTrials.gov record NCT01384643, source copy `cardio:ctgov-nct01384643-2013-04-12`, retrieved 2026-10-26)
- Primary completion: 2012-05 (actual) (ClinicalTrials.gov record NCT01384643, source copy `cardio:ctgov-nct01384643-2013-04-12`, retrieved 2026-10-26)
- Completion: 2012-05 (actual) (ClinicalTrials.gov record NCT01384643, source copy `cardio:ctgov-nct01384643-2013-04-12`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01384643, source copy `cardio:ctgov-nct01384643-2013-04-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01384643-2013-04-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Propofol on Renal Injury in Patients Undergoing Valvular Heart Surgery
- Condition: Heart Valve Disease
- Intervention (Drug): Propofol
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

## Provenance

Content hash: b68147d4ae4498effefcae825a50baffe120b3ae87216aec057c0737d5088ba5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
